161 related articles for article (PubMed ID: 21739463)
1. Proteomic analysis of the interleukin-4 (IL-4) response in hepatitis B virus-positive human hepatocelluar carcinoma cell line HepG2.2.15.
Yao Y; Li J; Lu Z; Tong A; Wang W; Su X; Zhou Y; Mu B; Zhou S; Li X; Chen L; Gou L; Song H; Yang J; Wei Y
Electrophoresis; 2011 Aug; 32(15):2004-12. PubMed ID: 21739463
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis of cellular protein alterations using a hepatitis B virus-producing cellular model.
Tong A; Wu L; Lin Q; Lau QC; Zhao X; Li J; Chen P; Chen L; Tang H; Huang C; Wei YQ
Proteomics; 2008 May; 8(10):2012-23. PubMed ID: 18491315
[TBL] [Abstract][Full Text] [Related]
3. Protein alteration of HepG2.2.15 cells induced by iron overload.
Fang C; Zhao C; Liu X; Yang P; Lu H
Proteomics; 2012 May; 12(9):1378-90. PubMed ID: 22589187
[TBL] [Abstract][Full Text] [Related]
4. HSPB1 is an intracellular antiviral factor against hepatitis B virus.
Tong SW; Yang YX; Hu HD; An X; Ye F; Ren H; Li SL; Zhang DZ
J Cell Biochem; 2013 Jan; 114(1):162-73. PubMed ID: 22887120
[TBL] [Abstract][Full Text] [Related]
5. [The expression of hepatitis B virus X protein and cyclooxygenase-2 in hepatitis B virus-related hepatocellular carcinoma: correlation with microangiogenesis and metastasis, and what is the possible mechanism].
Liu KG; Shao XL; Xie HH; Xu L; Zhao H; Guo ZH; Li L; Liu J
Zhonghua Gan Zang Bing Za Zhi; 2010 Nov; 18(11):831-6. PubMed ID: 21138631
[TBL] [Abstract][Full Text] [Related]
6. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
[TBL] [Abstract][Full Text] [Related]
7. IL-4 suppresses the expression and the replication of hepatitis B virus in the hepatocellular carcinoma cell line Hep3B.
Lin SJ; Shu PY; Chang C; Ng AK; Hu CP
J Immunol; 2003 Nov; 171(9):4708-16. PubMed ID: 14568946
[TBL] [Abstract][Full Text] [Related]
8. Stable expression and integrated hepatitis B virus genome in a human hepatoma cell line.
Wang LY; Li YG; Chen K; Li K; Qu JL; Qin DD; Tang H
Genet Mol Res; 2012 May; 11(2):1442-8. PubMed ID: 22653591
[TBL] [Abstract][Full Text] [Related]
9. Quantitative proteomic analysis of exosome protein content changes induced by hepatitis B virus in Huh-7 cells using SILAC labeling and LC-MS/MS.
Zhao X; Wu Y; Duan J; Ma Y; Shen Z; Wei L; Cui X; Zhang J; Xie Y; Liu J
J Proteome Res; 2014 Dec; 13(12):5391-402. PubMed ID: 25265333
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
[TBL] [Abstract][Full Text] [Related]
11. Proteome responses to stable hepatitis B virus transfection and following interferon alpha treatment in human liver cell line HepG2.
Wang J; Jiang D; Zhang H; Lv S; Rao H; Fei R; Wei L
Proteomics; 2009 Mar; 9(6):1672-82. PubMed ID: 19242931
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.
Eyre NS; Phillips RJ; Bowden S; Yip E; Dewar B; Locarnini SA; Beard MR
J Hepatol; 2009 Sep; 51(3):446-57. PubMed ID: 19596477
[TBL] [Abstract][Full Text] [Related]
13. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.
Chen JD; Yang HI; Iloeje UH; You SL; Lu SN; Wang LY; Su J; Sun CA; Liaw YF; Chen CJ;
Gastroenterology; 2010 May; 138(5):1747-54. PubMed ID: 20114048
[TBL] [Abstract][Full Text] [Related]
14. Effects of cell cycle on telomerase activity and on hepatitis B virus replication in HepG2 2.2.15 cells.
Huang YQ; Wang LW; Yan SN; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):543-7. PubMed ID: 15567742
[TBL] [Abstract][Full Text] [Related]
15. Protein profile in hepatitis B virus replicating rat primary hepatocytes and HepG2 cells by iTRAQ-coupled 2-D LC-MS/MS analysis: Insights on liver angiogenesis.
Zhang J; Niu D; Sui J; Ching CB; Chen WN
Proteomics; 2009 May; 9(10):2836-45. PubMed ID: 19405029
[TBL] [Abstract][Full Text] [Related]
16. JS-K, a nitric oxide prodrug, induces DNA damage and apoptosis in HBV-positive hepatocellular carcinoma HepG2.2.15 cell.
Liu Z; Li G; Gou Y; Xiao D; Luo G; Saavedra JE; Liu J; Wang H
Biomed Pharmacother; 2017 Aug; 92():989-997. PubMed ID: 28605880
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of hepatitis B virus replication and proteomic analysis of HepG2.2.15 cell line after cyclosporine A treatment.
Xie HY; Xia WL; Zhang CC; Wu LM; Ji HF; Cheng Y; Zheng SS
Acta Pharmacol Sin; 2007 Jul; 28(7):975-84. PubMed ID: 17588333
[TBL] [Abstract][Full Text] [Related]
18. Whole genome expression profiling of hepatitis B virus-transfected cell line reveals the potential targets of anti-HBV drugs.
Ding XR; Yang J; Sun DC; Lou SK; Wang SQ
Pharmacogenomics J; 2008 Feb; 8(1):61-70. PubMed ID: 17505500
[TBL] [Abstract][Full Text] [Related]
19. [Effect of cell cycle on telomerase activity of hepatoma cells and its relationship with replication of hepatitis B virus].
Yan SN; Deng B; Gong ZJ
Ai Zheng; 2003 May; 22(5):504-7. PubMed ID: 12753712
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus X protein stimulates IL-6 expression in hepatocytes via a MyD88-dependent pathway.
Xiang WQ; Feng WF; Ke W; Sun Z; Chen Z; Liu W
J Hepatol; 2011 Jan; 54(1):26-33. PubMed ID: 20937539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
